Genomictree Inc. (228760) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.028x

Based on the latest financial reports, Genomictree Inc. (228760) has a cash flow conversion efficiency ratio of -0.028x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.21 Billion ≈ $-2.18 Million USD) by net assets (₩115.31 Billion ≈ $78.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Genomictree Inc. - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Genomictree Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 228760 total liabilities for a breakdown of total debt and financial obligations.

Genomictree Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genomictree Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Chia Hsin Cement Corp TW:1103	0.008x
Erdene Resource Development Corp TO:ERD	-0.018x
Siyaram Silk Mills Limited NSE:SIYSIL	-0.038x
Agung Podomoro Land Tbk JK:APLN	-0.004x
SRINANAPORN MARKETING BK:SNNP-R	N/A
Automatic Bank Services Ltd TA:SHVA	0.086x
Arlandastad Group AB ST:AGROUP	-0.004x
Compagnie d Entreprises CFE SA BR:CFEB	0.362x

Annual Cash Flow Conversion Efficiency for Genomictree Inc. (2020–2025)

The table below shows the annual cash flow conversion efficiency of Genomictree Inc. from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see Genomictree Inc. stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩115.31 Billion ≈ $78.14 Million	₩-10.19 Billion ≈ $-6.91 Million	-0.088x	+19.40%
2024-12-31	₩124.32 Billion ≈ $84.25 Million	₩-13.63 Billion ≈ $-9.24 Million	-0.110x	-26.02%
2023-12-31	₩125.03 Billion ≈ $84.73 Million	₩-10.88 Billion ≈ $-7.37 Million	-0.087x	-317.38%
2022-12-31	₩107.05 Billion ≈ $72.55 Million	₩4.29 Billion ≈ $2.90 Million	0.040x	+160.38%
2021-12-31	₩115.10 Billion ≈ $78.00 Million	₩-7.63 Billion ≈ $-5.17 Million	-0.066x	+38.01%
2020-12-31	₩95.26 Billion ≈ $64.55 Million	₩-10.19 Billion ≈ $-6.90 Million	-0.107x	--

About Genomictree Inc.

KQ:228760 Korea Biotechnology

Market Cap

$279.13 Million

₩411.89 Billion KRW

Market Cap Rank

#15256 Global

#569 in Korea

Share Price

₩17150.00

Change (1 day)

-3.11%

52-Week Range

₩11850.00 - ₩32000.00

All Time High

₩38550.00